1. Home
  2. PCT vs HRMY Comparison

PCT vs HRMY Comparison

Compare PCT & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCT
  • HRMY
  • Stock Information
  • Founded
  • PCT 2015
  • HRMY 2017
  • Country
  • PCT United States
  • HRMY United States
  • Employees
  • PCT N/A
  • HRMY N/A
  • Industry
  • PCT Environmental Services
  • HRMY Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCT Utilities
  • HRMY Health Care
  • Exchange
  • PCT Nasdaq
  • HRMY Nasdaq
  • Market Cap
  • PCT 2.9B
  • HRMY 2.1B
  • IPO Year
  • PCT N/A
  • HRMY 2020
  • Fundamental
  • Price
  • PCT $13.63
  • HRMY $32.50
  • Analyst Decision
  • PCT Strong Buy
  • HRMY Strong Buy
  • Analyst Count
  • PCT 4
  • HRMY 9
  • Target Price
  • PCT $15.50
  • HRMY $55.33
  • AVG Volume (30 Days)
  • PCT 2.3M
  • HRMY 662.4K
  • Earning Date
  • PCT 11-06-2025
  • HRMY 10-28-2025
  • Dividend Yield
  • PCT N/A
  • HRMY N/A
  • EPS Growth
  • PCT N/A
  • HRMY 58.41
  • EPS
  • PCT N/A
  • HRMY 3.10
  • Revenue
  • PCT $3,230,000.00
  • HRMY $772,527,000.00
  • Revenue This Year
  • PCT N/A
  • HRMY $20.09
  • Revenue Next Year
  • PCT $310.50
  • HRMY $16.74
  • P/E Ratio
  • PCT N/A
  • HRMY $10.50
  • Revenue Growth
  • PCT N/A
  • HRMY 17.74
  • 52 Week Low
  • PCT $5.40
  • HRMY $26.47
  • 52 Week High
  • PCT $17.37
  • HRMY $41.61
  • Technical
  • Relative Strength Index (RSI)
  • PCT 51.95
  • HRMY 31.26
  • Support Level
  • PCT $13.04
  • HRMY $32.87
  • Resistance Level
  • PCT $13.74
  • HRMY $37.05
  • Average True Range (ATR)
  • PCT 0.65
  • HRMY 1.15
  • MACD
  • PCT 0.01
  • HRMY -0.60
  • Stochastic Oscillator
  • PCT 37.53
  • HRMY 13.34

About PCT PureCycle Technologies Inc. Common stock

PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: